Avai BioAVAI -6.27%24 Current Ratio is 0.02 as of Dec. 2025, which is 89% below its 10-year median of 0.18. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 2,862 Software companies, Avai Bio ranks worse than 99.23% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Avai Bio's current ratio for the quarter that ended in Dec. 2025 was 0.02.
Avai Bio has a current ratio of 0.02. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Avai Bio has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Avai Bio's Current Ratio or its related term are showing as below:
AVAI'
s Current Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.18 Max: 1.6
Current: 0.02
During the past 8 years, Avai Bio's highest Current Ratio was 1.60. The lowest was 0.01. And the median was 0.18.
AVAI's Current Ratio is ranked worse than 99.23% of 2862
companies
in the Software industry
Industry Median: 1.81
vs AVAI: 0.02
Avai Bio (OTCPK:AVAI) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Avai Bio Current Ratio Related Terms
Avai Bio Current Ratio Historical Data
* Premium members only.
The historical data trend for Avai Bio's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Avai Bio's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avai Bio Current Ratio vs Software Industry
For the Software industry and Technology sector, Avai Bio's Current Ratio distribution charts can be found below:
* The bar in red indicates where Avai Bio's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avai Bio (AVAI) has a Current Ratio of 0.02 as of Dec. 2025. This is 89% below median its historical median of 0.18. Over the past decade, Avai Bio's Current Ratio has ranged from 0.01 to 1.60. According to the industry distribution chart, Avai Bio ranks #2840 out of 2862 companies in the Software industry, placing it in the top 99.2%.
Is Avai Bio's Current Ratio too high?
Avai Bio's current Current Ratio of 0.02 is 89% below median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.60. The Software industry median Current Ratio is 1.81. Avai Bio's value of 0.02 is 98.9% below this industry median. Based on the distribution chart, Avai Bio ranks #2840 out of 2862 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Current Ratio compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #2840 out of 2862 companies for Current Ratio. This places Avai Bio in the lower half of its industry. The industry median Current Ratio is 1.81. Avai Bio's value of 0.02 is 98.9% below this benchmark. Historically, Avai Bio's own Current Ratio has ranged from 0.01 to 1.60 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 1.81, Avai Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Software company?
The median Current Ratio among Software companies is 1.81, based on 2,862 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avai Bio's current Current Ratio of 0.02 is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median Current Ratio is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avai Bio's current Current Ratio is 0.02, which is 89% below median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Current Ratio of 0.02. The current Current Ratio is 0.02, which is 89% below median its 10-year median of 0.18 and 98.9% below the Software industry median of 1.81. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Avai Bio (AVAI), the current Current Ratio is 0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score
Get the complete analysis for AVAI
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAI has been successfully added to your 
